Quality of Life and Symptom Management in Patients With Bladder Cancer
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Learning about quality of life and symptom management in patients with bladder cancer may help doctors learn about the effects of treatment and plan the best treatment.
PURPOSE: This clinical trial is studying of quality of life and symptom management in patients with bladder cancer.
| Condition |
|---|
|
Bladder Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Cross-Sectional |
| Official Title: | A Qualitative Study of Patients With Non-Invasive Bladder Cancer |
- Health-related quality of life (HRQOL) and symptom management in patients with bladder cancer [ Time Frame: One timepoint ] [ Designated as safety issue: No ]Study is a retrospective qualitative study of nonmuscle-invasive bladder cancer patients using a semi-structured interview protocol.
| Enrollment: | 28 |
| Study Start Date: | May 2008 |
| Study Completion Date: | September 2010 |
| Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
- To identify aspects of health-related quality of life (HRQOL) and symptom management in patients with non-invasive, low- or high-risk bladder cancer.
- To obtain feedback on data collection methods to enhance acceptability in these patients.
OUTLINE: Patients undergo a 10-minute screening in person or by phone to obtain demographic data and medical information (e.g., bladder cancer diagnosis and treatment history). Additional information is obtained from the clinical databases at the Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center. Patients who are eligible for the study are added to a waiting list for 1 of 4 focus groups based on disease status (high-risk or low-risk non-invasive bladder cancer) and gender. Patients participate in a 1.5- to 2-hour focus group discussion about the impact of bladder cancer on their quality of life and relationships. Patients receive information about community and Internet-based resources at the end of each group session.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Urology specialty clinic
DISEASE CHARACTERISTICS:
Diagnosis of bladder cancer within the past 4 years
- Non-invasive disease
- Low- or high-risk disease
- Recruited from patients at the Baylor College of Medicine Scott Department of Urology clinics, the Michael E. DeBakey Veteran Affairs Medical Center, and the Urology Clinic at MD Anderson Cancer Center OR from participants at a community event
PATIENT CHARACTERISTICS:
- Not pregnant
- Able to read, speak, and understand English
PRIOR CONCURRENT THERAPY:
- Not specified
Contacts and Locations| United States, Texas | |
| Dan L. Duncan Cancer Center at Baylor College of Medicine | |
| Houston, Texas, United States, 77030 | |
| Veterans Affairs Medical Center - Houston | |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: | David M. Latini, PhD | Baylor College of Medicine |
More Information
Additional Information:
No publications provided
| Responsible Party: | David Latini, Assistant Professor, Baylor College of Medicine |
| ClinicalTrials.gov Identifier: | NCT00772018 History of Changes |
| Other Study ID Numbers: | CDR0000600591, BCM-H-21570 |
| Study First Received: | October 12, 2008 |
| Last Updated: | February 1, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Baylor College of Medicine:
|
stage 0 bladder cancer |
Additional relevant MeSH terms:
|
Urinary Bladder Neoplasms Urologic Neoplasms Urogenital Neoplasms Neoplasms by Site |
Neoplasms Urinary Bladder Diseases Urologic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013